Last week, the Food and Drug Administration ignored the advice of its own expert advisory committee and approved the first new treatment for Alzheimer’s in 18 years. Called Aduhelm, it carries a substantial risk of painful brain swelling and bleeding, requires monthly infusions, and comes with an eye-popping list price of $56,000 per year. These caveats might be fine if[Read More...]
A new 'seaweed drug' called Oligomannate has been approved in China for the treatment of “mild to moderate Alzheimer’s disease and improving cognitive function.”
The post Exciting: New ‘Seaweed-Based’ Alzheimer’s Drug Shows Extreme Promise appeared first on Natural Society.
A decrease of ca. 1 million Americans with dementia may be due to better control of cardiovascular risk factors like high blood pressure and diabetes.
The post Dementia Rates in the U.S. Fell 24% from 2000 to 2012, But… appeared first on Natural Society.
Wow... I mean, just... well, wow. For several months, a Certain Authoritative Figure and I have been speculating - more off the record than […]
The post THAT DEMENTIA IN CONGRESS MAY BE REAL… appeared first on Giza Death Star.
And while you're contemplating today's main blog, Mr. M.D. sent this along:
Tiny human brains grown in lab could one day be used to…
The post TIDBIT: GROWING MINI-BRAINS TO COMBAT ALZHEIMERS appeared first on Giza Death Star.
I recently joined good friend Chuck Ochelli for the first hour of this Friday show. We discussed the most recent Trump media shit show, mainly exploring the “scandal” over whether or not CNN blackmailed a Reddit user. Chuck and I talked about the strange symbiotic role that the alt-media and the right wing has with outlets such as CNN. I also talk about Alan Dershowitz’s latest transformation and how he has emerged from the shadows of scandal and Jeffrey Epstein with the help of his minion Mike Cernovich.
A new study from Texas A&M University and published in the Journal of Toxicology suggests that oral nicotine may actually prevent the brain from aging, and thus developing Alzheimer’s and Parkinson’s disease.
Although there is no accepted treatment for Alzheimer’s yet, a new study shows that we may find a little hope in a common period pain medication drug. In fact, it may completely reverse the symptoms of Alzheimer’s.
The research, led by Dr. David Brough at the University of Manchester, found that the non-steroidal anti-inflammatory drug (NSAID), mefenamic acid, which is often used to treat menstrual pain, was able to completely reverse symptoms of Alzheimer’s in mice. But could the benefits extend to humans?
Acupuncture may help those who are suffering from the early stages of dementia, a new study suggests. This stage, known as mild cognitive impairment (MCI) is somewhere between that of memory loss due to normal aging and memory loss due to dementia. This new study is one of the first that looks at the combination of Western and Eastern medicine, suggesting that acupuncture may work best if they are used in concert with one another.
Two new studies have shown that Alzheimer’s disease is frequently misdiagnosed. The rate of misdiagnosis may even be as high as 1 in 5 people being diagnosed incorrectly, which can lead to significant emotional consequences.
